Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 6, 1998, Pages 505-512

  Zagaja, Gregory P ^a   Shrivastav, Maneesh ^a   Fleig, Matthew J ^a   Marton, Laurence J ^b   Rinker Schaeffer, Carrie W ^a   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apoptosis; Polyamine analogues; Prostate cancer

Indexed keywords

1,19 DI(ETHYLAMINO) 5,10,15 TRIAZONONADECANE; DNA FRAGMENT; N1,N11 DIETHYLNORSPERMINE; POLYAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL KILLING; CELL NUCLEUS; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG SENSITIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEPHROTOXICITY; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RAT; STAINING; TISSUE NECROSIS; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; KIDNEY; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RATS; SPERMINE; TUMOR CELLS, CULTURED;

EID: 0031913230     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050774     Document Type: Article

References (37)

1. Armstrong DK, Isaac JT, Ottaviano YL, Davidson NE (1992) Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res 52: 3418
2. Basu HS, Feuerstein BG, Deen DF, Lubich WP, Bergeron RJ, Samejima K, Marton LJ (1989) Correlation between the effects of polyamine analogs on DNA confirmation and cell growth. Cancer Res 49: 5591
3. Basu HS, Pellarin M, Feuerstein BG, Shirahata A, Samejima K, Deen DF, Marton LJ (1993) Interaction of a polyamine analogue 1, 19-bis-(ethylamino)-5,10.15-triazanonadecane (BE-4-4-4-4) with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines. Cancer Res 53: 3948
4. 12-bis(ethyl)spermine homologs against human MALME-3 melanoma xenografts. Cancer Res 52: 2424
5. 11-diethylnorspermine administered by multiple injection or continuous infusion. Clin Cancer Res 1: 847
6. Chang BK, Bergeron RJ, Porter CW, Liong Y (1992) Antitumor effects of N-alkylatcd polyamine analogs in human pancreatic adenocarcinoma models. Cancer Chemother Rep 30: 183
7. Dolan ME, Fleig MJ, Feuerstein BG, Basu HS, Luk GD, Casero RA, Marton LJ (1994) Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts. Cancer Res 54: 4698
8. Furuya Y, Lundmo P, Short AD, Gill DL Isaacs JT (1994) The role of calcium. pH. and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsieargin. Cancer Res 54: 6167
9. Ghoda L, Basu HS, Porter CW, Marton LJ, Coffino P (1992) Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs. Mol Pharmacol 42: 302
10. Gingrich JR, Tucker JA, Walther PJ, Day JW, Poulton SH, Webb KS (1991) Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J Urol 146: 915
11. Heby O, Perrson L (1990) Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 15: 153
12. Hessels J, Kingma AW, Ferwerda H, Keij J, Van Der Berg GA, Musket FAJ (1989) Microbial flora in the gastrointestinal tract abolishes cytostatic effects of α-difluoromethylornithine in vivo. Int J Cancer 43: 1155
13. Huggins C, Hodges CV (1941) The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293
14. Igarashi K, Koga K, He Y, Shimogori T, Ekimoto H, Kashiwagi K, Shirahata A (1995) Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane. Cancer Res 55: 2615
15. Iizumi T, Yazuki T, Kanoh S, Kondo I, Koiso K (1987) Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J Urol 137: 1304
16. Jänne J, Alhonen L, Leinonen P (1991) Polyamines: from molecular biology to clinical applications. Ann Med 23: 241
17. Jeffers L, Church D, Basu H, Marton L, Wilding G (1997) Effects of the polyamine analogues BE-4-4-4-4, BE-3-7-3, and BE-3-3-3 on the proliferation of three prostate cancer cell lines. Cancer Chemother Pharmacol 40: 172
18. Libby PR, Bergeron RJ, Porter CW (1989) Structure-function correlations of polyamine analog-induced increases in spermidine/spermine acetyltransferase activity. Biochem Pharmacol 38: 1435
19. Marton LJ, Pegg AE (1995) Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35: 55
20. McCloskey DE, Casero RA, Woster PM, Duvidson NE (1995) Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue. Cancer Res 55: 3233
21. McCloskey DE, Prestigiacomo LJ, Woster PM, Casero RA, Davidson NE (1996) Growth and biochemical effects of symmetrically and unsymmetrically substituted polyamine analogs on human prostate cancer cell lines. Proc Am Assoc Cancer Res 37: 400
22. McCloskey DE, Yang J, Woster PM, Davidson NE, Casero RJ (1996) Polyamine analogue induction of programmed cell death in human lung tumor cells. Clin Cancer Res 2: 441
23. Pegg A (1988) Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759
24. 12-bis(ethyl)spermine and related compounds on growth and polyamine acetylation, content, and excretion in human colon tumor cells. J Biol Chem 264: 11744
25. 11-bis(ethyl)norspermine and related compounds. Biochem J 267: 331
26. Porter CW, Sufrin JR (1986) Interference with polyamine biosynthesis and/or functioning by analogs of polyamines or methionine as a potential anticancer chemotherapy strategy. Anticancer Res 6: 525
27. Porter CW, McManis J, Casero R, Bergeron RJ (1987) Relative abilities of bis(ethyl)-derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit cell growth. Cancer Res 47: 2821
28. Porter CW, Ganis B, Libby PR, Bergeron RJ (1991) Correlations between polyamine analogue-induced increases in spermidine-spermine N-l-acetyltransferase activity polyamine pool depletion and growth inhibition in human melanoma cell lines. Cancer Res 51: 3715
29. 11 bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res 53: 581
30. Raghaven D (1988) Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs. Semin Oncol 15: 371
31. Rodman LE, Heath JE, Trang JM, Wood RD, Tomaszewski JE, Smith AC, Page JG (1995) Preclinical toxicology and pharmacology studies of BE4×4 (NSC640506 in Beagle dogs. Proc Am Assoc Cancer Res 36: 2194
32. Seiler N, Sarhan S, Grauffel C, Jones R, Knodgen B, Moulinoux J-P (1990) Endogenous and exogenous polyamines in support of tumor growth. Cancer Res 50: 5077
33. Sinha AA, Blackhard CE, Seal US (1977) A critical analysis of tumor morphology and hormone treatment in the untreated and estrogen treated responsive and refractory human prostatic carcinoma. Cancer 40: 2836
34. Tabor H, Tabor CW (1964) Spermidine, spermine and related amines. Pharmacol Rev 16: 245
35. Tomaydo MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24: 148
36. Williams-Ashman HG, Canellakis ZN (1979) Polyamines in mammalian biology and medicine. Perspect Biol Med 22: 421
37. Williams-Ashman HG, Pegg AE, Lockwood DH (1969) Mechanisms and regulation of polyamine and putrescine biosynthesis in male genital glands and other tissues of mammals. Adv Enzyme Regul 7: 291